TRCNF — Transnational Cannabis Income Statement
0.000.00%
Last trade - 00:00Consumer DefensivesHighly SpeculativeMicro Cap
- $0.00m
- $23.64m
Annual income statement for Transnational Cannabis, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.
2015 February 28th | 2016 February 29th | 2017 February 28th | 2018 February 28th | 2019 February 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.052 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | — | 0.016 | 0 | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.546 | 0.341 | 0.737 | 0.989 | 60.3 |
| Operating Profit | -0.546 | -0.29 | -0.737 | -0.989 | -60.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.551 | -0.299 | -0.778 | -0.989 | -60.3 |
| Net Income After Taxes | -0.551 | -0.299 | -0.778 | -0.989 | -60.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.551 | -0.299 | -0.778 | -0.989 | -60.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.551 | -0.299 | -0.778 | -0.989 | -60.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.078 | -0.036 | -0.039 | -0.06 | -0.255 |
| Dividends per Share |